TG THERAPEUTICS, INC. Other General and Administrative Expense
TG THERAPEUTICS, INC. (TGTX) reported Other General and Administrative Expense of $41.52 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2021-03-01
- TG THERAPEUTICS, INC. other general and administrative expense for the quarter ending 2020-12-31 was $16.15M, a 452.33% increase year-over-year.
- TG THERAPEUTICS, INC. other general and administrative expense for the quarter ending 2020-09-30 was $11.58M, a 399.10% increase year-over-year.
- TG THERAPEUTICS, INC. other general and administrative expense for the quarter ending 2020-06-30 was $8.62M, a 272.87% increase year-over-year.
- TG THERAPEUTICS, INC. other general and administrative expense for the quarter ending 2020-03-31 was $5.17M, a 165.37% increase year-over-year.
- TG THERAPEUTICS, INC. other general and administrative expense for fiscal 2020 was $41.52M, a 336.90% increase from fiscal 2019.
- TG THERAPEUTICS, INC. other general and administrative expense for fiscal 2019 was $9.50M, a 20.72% increase from fiscal 2018.
- TG THERAPEUTICS, INC. other general and administrative expense for fiscal 2018 was $7.87M, a 30.50% increase from fiscal 2017.
- TG THERAPEUTICS, INC. other general and administrative expense for fiscal 2017 was $6.03M, a 17.79% increase from fiscal 2016.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 3 month as first filed | Other General and Administrative Expense 6 month | Other General and Administrative Expense 6 month as first filed | Other General and Administrative Expense 9 month | Other General and Administrative Expense 9 month as first filed | Other General and Administrative Expense 12 month | Other General and Administrative Expense 12 month as first filed | Other General and Administrative Expense 13 month | Other General and Administrative Expense 15 month | Other General and Administrative Expense 16 month | Other General and Administrative Expense 18 month | Other General and Administrative Expense 19 month | Other General and Administrative Expense 22 month | Other General and Administrative Expense 25 month | Other General and Administrative Expense 28 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $16.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $27.73M derived: sum of 2 quarters · filed 2021-03-01 | $36.35M derived: sum of 3 quarters · filed 2021-03-01 | $41.52M 10-K · filed 2021-03-01 | ||||||||||||
| 2020-09-30 | $11.58M 10-Q · filed 2020-11-09 | $20.20M derived: sum of 2 quarters · filed 2020-11-09 | $25.37M 10-Q · filed 2020-11-09 | $28.30M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2020-06-30 | $8.62M 10-Q · filed 2020-08-10 | $13.79M 10-Q · filed 2020-08-10 | $16.71M derived: sum of 3 quarters · filed 2021-03-01 | $19.03M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2020-03-31 | $5.17M 10-Q · filed 2020-05-11 | $8.10M derived: sum of 2 quarters · filed 2021-03-01 | $10.42M derived: sum of 3 quarters · filed 2021-03-01 | $12.73M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.25M derived: sum of 2 quarters · filed 2021-03-01 | $7.56M derived: sum of 3 quarters · filed 2021-03-01 | $9.50M 10-K · filed 2021-03-01 | ||||||||||||
| 2019-09-30 | $2.32M 10-Q · filed 2020-11-09 | $4.63M derived: sum of 2 quarters · filed 2020-11-09 | $6.58M 10-Q · filed 2020-11-09 | $8.24M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-06-30 | $2.31M 10-Q · filed 2020-08-10 | $4.26M 10-Q · filed 2020-08-10 | $5.92M derived: sum of 3 quarters · filed 2021-03-01 | $7.71M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-03-31 | $1.95M 10-Q · filed 2020-05-11 | $3.61M derived: sum of 2 quarters · filed 2021-03-01 | $5.39M derived: sum of 3 quarters · filed 2021-03-01 | $7.70M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2018-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.45M derived: sum of 2 quarters · filed 2021-03-01 | $5.75M derived: sum of 3 quarters · filed 2021-03-01 | $7.87M 10-K · filed 2021-03-01 | ||||||||||||
| 2018-09-30 | $1.78M 10-Q · filed 2019-11-12 | $4.09M derived: sum of 2 quarters · filed 2019-11-12 | $6.21M 10-Q · filed 2019-11-12 | $7.98M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2018-06-30 | $2.31M 10-Q · filed 2019-08-09 | $4.43M 10-Q · filed 2019-08-09 | $6.19M derived: sum of 3 quarters · filed 2020-03-02 | $7.59M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2018-03-31 | $2.12M 10-Q · filed 2019-05-10 | $3.89M derived: sum of 2 quarters · filed 2020-03-02 | $5.28M derived: sum of 3 quarters · filed 2020-03-02 | $6.82M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2017-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.17M derived: sum of 2 quarters · filed 2020-03-02 | $4.70M derived: sum of 3 quarters · filed 2020-03-02 | $6.03M 10-K · filed 2020-03-02 | $6.03M 10-K · filed 2018-03-15 | |||||||||||
| 2017-09-30 | $1.40M 10-Q · filed 2018-11-09 | $1.40M 10-Q · filed 2017-11-09 | $2.93M derived: sum of 2 quarters · filed 2018-11-09 | $4.27M 10-Q · filed 2018-11-09 | $4.27M 10-Q · filed 2017-11-09 | $5.59M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||
| 2017-06-30 | $1.53M 10-Q · filed 2018-08-09 | $1.53M 10-Q · filed 2017-08-09 | $2.87M 10-Q · filed 2018-08-09 | $2.87M 10-Q · filed 2017-08-09 | $4.19M derived: sum of 3 quarters · filed 2019-03-01 | $5.44M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||
| 2017-03-31 | $1.33M 10-Q · filed 2018-05-10 | $1.33M 10-Q · filed 2017-05-10 | $2.66M derived: sum of 2 quarters · filed 2019-03-01 | $3.91M derived: sum of 3 quarters · filed 2019-03-01 | $5.35M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||
| 2016-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.57M derived: sum of 2 quarters · filed 2019-03-01 | $4.02M derived: sum of 3 quarters · filed 2019-03-01 | $5.12M 10-K · filed 2019-03-01 | $5.12M 10-K · filed 2017-03-16 | |||||||||||
| 2016-09-30 | $1.25M 10-Q · filed 2017-11-09 | $2.70M derived: sum of 2 quarters · filed 2017-11-09 | $3.80M 10-Q · filed 2017-11-09 | $4.89M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||
| 2016-06-30 | $1.45M 10-Q · filed 2017-08-09 | $2.55M 10-Q · filed 2017-08-09 | $3.64M derived: sum of 3 quarters · filed 2018-03-15 | $4.73M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||
| 2016-03-31 | $1.10M 10-Q · filed 2017-05-10 | $2.20M derived: sum of 2 quarters · filed 2018-03-15 | $3.28M derived: sum of 3 quarters · filed 2018-03-15 | $4.29M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||
| 2015-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.18M derived: sum of 2 quarters · filed 2018-03-15 | $3.19M derived: sum of 3 quarters · filed 2018-03-15 | $4.19M 10-K · filed 2018-03-15 | ||||||||||||
| 2015-09-30 | $1.09M 10-Q · filed 2016-11-09 | $2.09M derived: sum of 2 quarters · filed 2016-11-09 | $3.09M 10-Q · filed 2016-11-09 | $4.01M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2015-06-30 | $1.00M 10-Q · filed 2016-08-09 | $2.01M 10-Q · filed 2016-08-09 | $2.92M derived: sum of 3 quarters · filed 2017-03-16 | $3.81M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2015-03-31 | $1.00M 10-Q · filed 2016-05-10 | $1.92M derived: sum of 2 quarters · filed 2017-03-16 | $2.81M derived: sum of 3 quarters · filed 2017-03-16 | $3.51M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2014-12-31 | $913.28K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.80M derived: sum of 2 quarters · filed 2017-03-16 | $2.51M derived: sum of 3 quarters · filed 2017-03-16 | $3.41M 10-K · filed 2017-03-16 | ||||||||||||
| 2014-09-30 | $889.87K 10-Q · filed 2015-11-09 | $1.60M derived: sum of 2 quarters · filed 2015-11-09 | $2.50M 10-Q · filed 2015-11-09 | $3.16M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-06-30 | $706.73K 10-Q · filed 2015-08-10 | $1.61M 10-Q · filed 2015-08-10 | $2.27M derived: sum of 3 quarters · filed 2016-03-15 | $2.82M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-03-31 | $903.52K 10-Q · filed 2015-05-11 | $1.57M derived: sum of 2 quarters · filed 2016-03-15 | $2.12M derived: sum of 3 quarters · filed 2016-03-15 | $2.75M derived: sum of 4 quarters · filed 2016-03-15 | $5.68M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $662.73K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.21M derived: sum of 2 quarters · filed 2016-03-15 | $1.85M derived: sum of 3 quarters · filed 2016-03-15 | $2.50M 10-K · filed 2016-03-15 | $4.78M 10-K · filed 2014-03-07 | |||||||||||
| 2013-09-30 | $550.64K 10-Q · filed 2014-11-14 | $1.18M derived: sum of 2 quarters · filed 2014-11-14 | $1.83M 10-Q · filed 2014-11-14 | $2.33M derived: sum of 4 quarters · filed 2014-11-14 | $4.12M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $631.64K 10-Q · filed 2014-07-24 | $1.28M 10-Q · filed 2014-07-24 | $1.78M derived: sum of 3 quarters · filed 2014-07-24 | $2.25M derived: sum of 4 quarters · filed 2014-07-24 | $3.57M 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $651.46K 10-Q · filed 2014-05-14 | $1.15M derived: sum of 2 quarters · filed 2014-05-14 | $1.62M derived: sum of 3 quarters · filed 2014-05-14 | $2.01M derived: sum of 4 quarters · filed 2014-05-14 | $2.93M 10-Q · filed 2013-05-14 | |||||||||||
| 2012-12-31 | $501.12K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $963.55K derived: sum of 2 quarters · filed 2014-03-07 | $1.36M derived: sum of 3 quarters · filed 2014-03-07 | $1.82M 10-K · filed 2014-03-07 | $2.28M 10-K · filed 2013-03-21 | |||||||||||
| 2012-09-30 | $462.43K 10-Q · filed 2013-11-14 | $858.47K derived: sum of 2 quarters · filed 2013-11-14 | $1.31M 10-Q · filed 2013-11-14 | $1.77M derived: sum of 4 quarters · filed 2013-11-14 | $1.78M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $396.04K 10-Q · filed 2013-08-09 | $851.53K 10-Q · filed 2013-08-09 | $1.31M derived: sum of 3 quarters · filed 2013-08-09 | $1.32M derived: sum of 4 quarters · filed 2013-08-09 | $1.32M 10-Q/A · filed 2012-09-07 | |||||||||||
| 2012-03-31 | $455.49K 10-Q · filed 2013-05-14 | $909.51K derived: sum of 2 quarters · filed 2013-05-14 | $923.69K derived: sum of 3 quarters · filed 2013-05-14 | $923.69K 10-Q · filed 2012-05-14 | ||||||||||||
| 2011-12-31 | $454.02K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $468.20K derived: sum of 2 quarters · filed 2013-03-21 | $468.20K derived: sum of 3 quarters · filed 2013-03-21 | $468.20K 10-K · filed 2013-03-21 | ||||||||||||
| 2011-09-30 | $14.18K 10-Q · filed 2012-11-14 | $14.18K derived: sum of 2 quarters · filed 2012-11-14 | $14.18K 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | $0.00 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |